AXIS CAPITAL HOLDINGS LTD AXS-PE Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001214816-25-000115
cik 1214816
name AXIS CAPITAL HOLDINGS LTD
sic 6331
countryba BM
stprba
cityba PEMBROKE
zipba HM 08
bas1 92 PITTS BAY ROAD
bas2
baph (441) 496-2600
countryma BM
stprma
cityma PEMBROKE
zipma HM 08
mas1 92 PITTS BAY ROAD
mas2
countryinc
stprinc
ein 000000000
former
changed
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250430
accepted 2025-04-30 16:23:00.0
prevrpt 0
detail 1
instance axs-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001214816-25-000115 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -152376000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Private Equity Funds;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Real Estate Funds;
0001214816-25-000115 20241231 Alternative Investment 291640000.0000 USD 0 us-gaap/2024 Financial Instrument= Real Estate Funds;
0001214816-25-000115 20241231 Alternative Investment 171048000.0000 USD 0 us-gaap/2024 Investment Type= Direct Lending Funds;
0001214816-25-000115 20250331 Alternative Investment 938562000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20250331 Alternative Investment 36386000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20250331 Alternative Investment 291564000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Real Estate Funds;
0001214816-25-000115 20250331 Cash And Cash Equivalents At Carrying Value 2757213000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 3690000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 53000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 59000.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 852534000.0000 USD 0 us-gaap/2024 Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 879004000.0000 USD 0 us-gaap/2024 Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 122536000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 147223000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 1539832000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 729939000.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 1184845000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 110817000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2518006000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2518006000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 4493868000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 1557554000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff 1926000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20250331 Deferred Policy Acquisition Cost Amortization Expense 264581000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001214816-25-000115 20240331 Dividends Preferred Stock Cash 7563000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001214816-25-000115 20240331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -14090000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Equity Securities Fv Ni 314042000.0000 USD 0 us-gaap/2024 Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20250331 Equity Securities Fv Ni 574379000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Equity Securities Fv Ni 2616000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Common Stock;
0001214816-25-000115 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001214816-25-000115 20241231 Equity Securities Fv Ni Cost 188771000.0000 USD 0 us-gaap/2024 Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20250331 Equity Securities Fv Ni Cost 538378000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Equity Securities Fv Ni Cost 294350000.0000 USD 0 us-gaap/2024 Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20241231 Held To Maturity Securities Fair Value 321134000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20250331 Income Loss From Equity Method Investments 2291000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Income Taxes Paid Net 6796000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Increase Decrease Due From Affiliates -236000000.0000 USD 4 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Loan Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20250331 Increase Decrease In Reinsurance Recoverable On Paid Losses And Loss Expenses -1064000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20240331 Increase Decrease In Unearned Premiums 611974000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Increase Decrease In Unearned Premiums 653052000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Interest Expense 17147000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Investment Income Net For Investments And Cash And Cash Equivalents 207713000.0000 USD 1 0001214816-25-000115 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20250331 Investments 14531469000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Liability For Claims And Claims Adjustment Expense 16630897000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Liability For Claims And Claims Adjustment Expense 17489459000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Marketable Securities Gain Loss Excluding Other Than Temporary Impairments -24871000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20250331 Marketable Securities Gain Loss Excluding Other Than Temporary Impairments -32384000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20250331 Net Cash Provided By Used In Financing Activities -511659000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Net Realized And Unrealized Gain Loss On Alternative Investments 22410000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20241231 Notes Payable 1315179000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent 115337000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20240331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent -8951000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 115181000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Other Operating Income Expense Net 8340000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Other Operating Income Expense Net 3422000.0000 USD 1 us-gaap/2024 Business Segments= Reinsurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Other Short Term Investments 91330000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001214816-25-000115 20250331 Payables To Broker Dealers And Clearing Organizations 193752000.0000 USD 0 srt/2024
0001214816-25-000115 20241231 Payments For Advance To Affiliate 253000000.0000 USD 4 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Loan Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20250331 Payments For Advance To Affiliate 68696000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Payments Of Dividends Preferred Stock And Preference Stock 7563000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Premiums Earned Net 1010086000.0000 USD 1 us-gaap/2024 Business Segments= Insurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Premiums Receivable At Carrying Value 3725518000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Prepaid Reinsurance Premiums 2175425000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Proceeds From Interest Received 6000000.0000 USD 1 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Loan Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20240331 Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities 39791000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Reinsurance Recoverables Allowance 43445000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Reinsurance Recoverables On Paid Losses 546287000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Revenues 1522106000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20231231 Stockholders Equity -347659000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20231231 Stockholders Equity -3746732000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001214816-25-000115 20250331 Stockholders Equity 550000000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001214816-25-000115 20250331 Stockholders Equity 7492484000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001214816-25-000115 20250331 Stockholders Equity -4364319000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001214816-25-000115 20250331 Stock Issued During Period Value Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations -29059000.0000 USD 1 0001214816-25-000115 Equity Components= Additional Paid In Capital;
0001214816-25-000115 20240331 Treasury Stock Value Acquired Cost Method 75728000.0000 USD 1 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20241231 Unearned Premiums 5211865000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Weighted Average Number Of Diluted Shares Outstanding 85693000.0000 shares 1 us-gaap/2024
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001214816-25-000115 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 9800000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20241231 Alternative Investment 838048000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share;
0001214816-25-000115 20241231 Alternative Investment 29751000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20241231 Alternative Investment 320690000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Private Equity Funds;
0001214816-25-000115 20241231 Alternative Investment 24919000.0000 USD 0 us-gaap/2024 Investment Type= Hedge Funds Multistrategy;
0001214816-25-000115 20241231 Alternative Investment 121981000.0000 USD 0 us-gaap/2024 Investment Type= Other Privately Held Investments;
0001214816-25-000115 20241231 Alternative Investment 291640000.0000 USD 0 us-gaap/2024 Investment Type= Real Estate Funds;
0001214816-25-000115 20241231 Alternative Investment 21000000.0000 USD 0 us-gaap/2024 Investment Type= Real Estate Funds; Redemption Frequency= Annual Redemption;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Private Equity Funds;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Real Estate Funds;
0001214816-25-000115 20250331 Alternative Investment 841542000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share;
0001214816-25-000115 20250331 Alternative Investment 167425000.0000 USD 0 us-gaap/2024 Investment Type= Direct Lending Funds;
0001214816-25-000115 20250331 Assets 33249174000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Cash And Cash Equivalents At Carrying Value 2143471000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1841574000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Common Stock Shares Outstanding 82984000.0000 shares 0 us-gaap/2024
0001214816-25-000115 20250331 Comprehensive Income Net Of Tax 309252000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 3938000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2767315000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 9238215000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 1184845000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2802986000.0000 USD 0 us-gaap/2024 Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 9180589000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 714525000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 189739000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 1557554000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 72227000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20240331 Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff 8000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss 128906000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Deferred Policy Acquisition Cost Amortization Expense 264581000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Deferred Policy Acquisition Costs 626104000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Dividends Preferred Stock Cash 7563000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001214816-25-000115 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 9440000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Equity Securities Fv Ni 256727000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Common Stock;
0001214816-25-000115 20250331 Equity Securities Fv Ni 251367000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20250331 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 272499000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Foreign Currency Transaction Gain Loss Before Tax 23552000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Foreign Currency Transaction Gain Loss Before Tax 23552000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20250331 Held To Maturity Securities Fair Value 260734000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20240331 Increase Decrease Due From Affiliates -25000000.0000 USD 1 us-gaap/2024 Counterparty Name= Third Party Reinsurer; Related Party Transaction= Loan Agreement With Third Party Reinsurer; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20240331 Increase Decrease In Accrued Investment Income Receivable 1411000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Increase Decrease In Other Operating Capital Net 258702000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Increase Decrease In Premiums Receivable And Reinsurance Payable Net 326816000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20240331 Increase Decrease In Prepaid Reinsurance Premiums 144311000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Increase Decrease In Reinsurance Recoverable On Paid Losses And Loss Expenses -98362000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20240331 Investment Income Net For Investments And Cash And Cash Equivalents 167383000.0000 USD 1 0001214816-25-000115 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20241231 Liabilities And Stockholders Equity 32520293000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 785925000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Mortgage Loans On Real Estate Commercial And Consumer Net 505697000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Net Cash Provided By Used In Investing Activities 462286000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Net Income Loss -28087000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20250331 Net Income Loss 194071000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001214816-25-000115 20250331 Operating Lease Right Of Use Asset 92299000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 192000.0000 USD 1 us-gaap/2024 Credit Loss Status= Aoci Gain Loss Debt Securities Available For Sale With Allowance For Credit Loss Parent; Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20240331 Other Operating Income Expense Net 21000.0000 USD 1 us-gaap/2024 Business Segments= Insurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20241231 Other Short Term Investments 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001214816-25-000115 20250331 Payments Of Dividends Preferred Stock And Preference Stock 7563000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments Related To Tax Withholding For Share Based Compensation 24514000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments To Acquire Equity Method Investments 4955000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments To Acquire Equity Method Investments 5000000.0000 USD 1 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Monarch Point Re;
0001214816-25-000115 20240331 Payments To Acquire Equity Securities Fv Ni 76270000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Payments To Acquire Mortgage Notes Receivable 1552000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments To Acquire Mortgage Notes Receivable 72000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Premiums Earned Net 1258041000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities 63780000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Proceeds From Sale And Maturity Of Other Investments 38027000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Proceeds From Sale Of Available For Sale Securities Debt 2367906000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20231231 Reinsurance Recoverable For Unpaid Claims And Claims Adjustments 6323083000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Restricted Cash And Cash Equivalents 575554000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Restructuring Settlement And Impairment Provisions 12299000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Restructuring Settlement And Impairment Provisions 12299000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20250331 Restructuring Settlement And Impairment Provisions 0.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Selling General And Administrative Expense 137793000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001214816-25-000115 20231231 Stockholders Equity -18177000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0001214816-25-000115 20231231 Stockholders Equity 2206000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001214816-25-000115 20240331 Stockholders Equity 550000000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001214816-25-000115 20241231 Stockholders Equity -267557000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001214816-25-000115 20241231 Stockholders Equity 2206000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001214816-25-000115 20241231 Stockholders Equity 550000000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001214816-25-000115 20250331 Stockholders Equity 2374804000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001214816-25-000115 20240331 Stock Issued During Period Value Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations 28556000.0000 USD 1 0001214816-25-000115 Equity Components= Treasury Stock Common;
0001214816-25-000115 20250331 Treasury Stock Common Shares 97929000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 11426000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001214816-25-000115 20241231 Advances From Federal Home Loan Banks 66000000.0000 USD 0 us-gaap/2024 Federal Home Loan Bank Advances Branch Of F H L B Bank= Federal Home Loan Bank Of Chicago;
0001214816-25-000115 20250331 Allowance For Credit Loss Period Increase Decrease -2729000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20241231 Alternative Investment 92230000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20241231 Alternative Investment 320690000.0000 USD 0 us-gaap/2024 Investment Type= Private Equity Funds;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20250331 Alternative Investment 133406000.0000 USD 0 us-gaap/2024 Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20250331 Alternative Investment 16625000.0000 USD 0 us-gaap/2024 Investment Type= Hedge Funds Multistrategy;
0001214816-25-000115 20250331 Alternative Investment 133406000.0000 USD 0 us-gaap/2024 Investment Type= Other Privately Held Investments;
0001214816-25-000115 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 457589000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Common Stock Shares Issued 176580000.0000 shares 0 us-gaap/2024
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 4183000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 3875000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 1547350000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 4941510000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 117288000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 1296928000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 4715799000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 729939000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 20832000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 1260731000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20250331 Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20240331 Dividends Common Stock Cash 37866000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001214816-25-000115 20241231 Equity Securities Fv Ni 314042000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Common Stock;
0001214816-25-000115 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20241231 Equity Securities Fv Ni 5867000.0000 USD 0 us-gaap/2024 Financial Instrument= Preferred Stock;
0001214816-25-000115 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Preferred Stock;
0001214816-25-000115 20241231 Equity Securities Fv Ni Cost 5843000.0000 USD 0 us-gaap/2024 Financial Instrument= Preferred Stock;
0001214816-25-000115 20231231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 6220000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Goodwill 66498000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 269636000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -24879000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20250331 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 236102000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve 278614000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Interest Expense 16572000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Interest Expense 16572000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20250331 Interest Paid Net 17099000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Liabilities 27346375000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Liabilities And Stockholders Equity 33249174000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Marketable Securities Gain Loss Excluding Other Than Temporary Impairments -13863000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Marketable Securities Gain Loss Excluding Other Than Temporary Impairments -25350000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Net Cash Provided By Used In Investing Activities 211039000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Net Income Loss 395459000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001214816-25-000115 20240331 Net Income Loss Available To Common Stockholders Basic 387896000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Net Realized And Unrealized Gain Loss On Alternative Investments 4973000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20250331 Other Assets 629844000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax -418000.0000 USD 1 us-gaap/2024 Credit Loss Status= Aoci Gain Loss Debt Securities Available For Sale With Allowance For Credit Loss Parent; Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 87058000.0000 USD 1 us-gaap/2024 Credit Loss Status= Aoci Gain Loss Debt Securities Available For Sale Without Allowance For Credit Loss Parent; Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20240331 Other Depreciation And Amortization 14257000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Other Liabilities 9000000.0000 USD 0 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Loan Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20240331 Other Operating Income Expense Net 8319000.0000 USD 1 us-gaap/2024 Business Segments= Reinsurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20241231 Other Short Term Investments 223666000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Other Short Term Investments 223666000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001214816-25-000115 20250331 Other Short Term Investments 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001214816-25-000115 20250331 Other Short Term Investments 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001214816-25-000115 20250331 Payments For Repurchase Of Common Stock 439992000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments Of Dividends Common Stock 39590000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20231231 Payments To Acquire Equity Method Investments 22000000.0000 USD 4 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Monarch Point Re;
0001214816-25-000115 20240331 Payments To Acquire Equity Method Investments 6791000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Payments To Acquire Held To Maturity Securities 46534000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Premiums Earned Net 340095000.0000 USD 1 us-gaap/2024 Business Segments= Reinsurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Premiums Earned Net 1340820000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Premiums Receivable Allowance For Doubtful Accounts 17339000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Proceeds From Maturities Prepayments And Calls Of Shortterm Investments 4510000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Proceeds From Sale Of Short Term Investments 19325000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Reinsurance Recoverables Allowance 43267000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Selling General And Administrative Expense 25580000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001214816-25-000115 20250331 Selling General And Administrative Expense 159163000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Stockholders Equity -384721000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20241231 Stockholders Equity -3930902000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001214816-25-000115 20250331 Stockholders Equity -110280000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20241231 Treasury Stock Common Shares 93596000.0000 shares 0 us-gaap/2024
0001214816-25-000115 20250331 Unearned Premiums 5859606000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Real Estate Funds;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20241231 Alternative Investment 121981000.0000 USD 0 us-gaap/2024 Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001214816-25-000115 20250331 Alternative Investment 97020000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20250331 Alternative Investment 167425000.0000 USD 0 us-gaap/2024 Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20250331 Alternative Investment 329542000.0000 USD 0 us-gaap/2024 Financial Instrument= Private Equity Funds;
0001214816-25-000115 20250331 Alternative Investment 48000000.0000 USD 0 us-gaap/2024 Investment Type= Real Estate Funds; Redemption Frequency= Quarterly Redemption;
0001214816-25-000115 20240331 Amortization Of Intangible Assets 2729000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3332767000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Ceded Premiums Written 46000000.0000 USD 1 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Retrocession Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20240331 Common Stock Shares Issued 176580000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20240331 Common Stock Shares Outstanding 84687000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20240331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 4237000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 12419905000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 753315000.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 110817000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 819608000.0000 USD 0 us-gaap/2024 Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 122536000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 11865480000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 856108000.0000 USD 0 us-gaap/2024 Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 714525000.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff 1926000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss 260665000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Equity Securities Fv Ni 5864000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Preferred Stock;
0001214816-25-000115 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Common Stock;
0001214816-25-000115 20250331 Equity Securities Fv Ni Cost 5843000.0000 USD 0 us-gaap/2024 Financial Instrument= Preferred Stock;
0001214816-25-000115 20241231 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 247775000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Income Loss From Equity Method Investments 1169000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Increase Decrease In Other Operating Capital Net 66765000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Increase Decrease In Reinsurance Recoverable 106132000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Interest Expense 17147000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20240331 Investment Income Net For Investments And Cash And Cash Equivalents 167383000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20241231 Liabilities 26430914000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Net Cash Provided By Used In Operating Activities 384139000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Notes Payable 1315555000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent -8951000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0001214816-25-000115 20240331 Stockholders Equity -411849000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001214816-25-000115 20250331 Treasury Stock Common Value 4364319000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Other Liabilities 528421000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Other Short Term Investments 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001214816-25-000115 20250331 Payments For Proceeds From Productive Assets 7273000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments To Acquire Available For Sale Securities Debt 2946681000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Preferred Stock Dividends Income Statement Impact 7563000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Premiums Receivable At Carrying Value 3169355000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Proceeds From Maturities Prepayments And Calls Of Shortterm Investments 102524000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Proceeds From Sale And Maturity Of Other Investments 34855000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Proceeds From Sale Of Equity Securities Fv Ni 97434000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Proceeds From Sale Of Equity Securities Fv Ni 82625000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Reinsurance Payable 1713798000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Reinsurance Recoverables On Paid Losses 531105000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Restructuring Settlement And Impairment Provisions 0.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20240331 Revenues 1424557000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Share Based Compensation 11829000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20231231 Stockholders Equity 2383030000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001214816-25-000115 20231231 Stockholders Equity 550000000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001214816-25-000115 20240331 Stockholders Equity 2206000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001214816-25-000115 20241231 Stockholders Equity -225617000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20250331 Treasury Stock Value Acquired Cost Method 24514000.0000 USD 1 us-gaap/2024 Class Of Stock= Common Stock; Share Repurchase Type= Employees;
0001214816-25-000115 20250331 Additional Paid In Capital Common Stock 2374804000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Advances From Federal Home Loan Banks 66380000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Private Equity Funds;
0001214816-25-000115 20241231 Alternative Investment 320690000.0000 USD 0 us-gaap/2024 Financial Instrument= Private Equity Funds;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Private Equity Funds;
0001214816-25-000115 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1383985000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Ceded Premiums Written 62000000.0000 USD 1 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Retrocession Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20241231 Common Stock Shares Issued 176580000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20250331 Common Stock Shares Outstanding 78651000.0000 shares 0 us-gaap/2024
0001214816-25-000115 20241231 Common Stock Value 2206000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 196000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 132116000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 11997330000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 4690383000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 1591388000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 74308000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 2550984000.0000 USD 0 us-gaap/2024 Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 819608000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 35671000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 856108000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 133742000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 1293874000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 4627610000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 189739000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2553843000.0000 USD 0 us-gaap/2024 Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20241231 Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20240331 Deferred Policy Acquisition Cost Amortization Expense 176029000.0000 USD 1 us-gaap/2024 Business Segments= Insurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20240331 Deferred Policy Acquisition Cost Amortization Expense 78225000.0000 USD 1 us-gaap/2024 Business Segments= Reinsurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20240331 Earnings Per Share Diluted 4.5300 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Equity Method Investments 214240000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Equity Securities Fv Ni 262591000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001214816-25-000115 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Common Stock;
0001214816-25-000115 20241231 Equity Securities Fv Ni 2638000.0000 USD 0 us-gaap/2024 Financial Instrument= Common Stock;
0001214816-25-000115 20250331 Equity Securities Fv Ni 317127000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001214816-25-000115 20250331 Equity Securities Fv Ni 3000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Preferred Stock;
0001214816-25-000115 20250331 Equity Securities Fv Ni 257252000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001214816-25-000115 20250331 Equity Securities Fv Ni 2616000.0000 USD 0 us-gaap/2024 Financial Instrument= Common Stock;
0001214816-25-000115 20250331 Equity Securities Fv Ni 314508000.0000 USD 0 us-gaap/2024 Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20250331 Equity Securities Fv Ni 5888000.0000 USD 0 us-gaap/2024 Financial Instrument= Preferred Stock;
0001214816-25-000115 20241231 Equity Securities Fv Ni Cost 520743000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Foreign Currency Transaction Gain Loss Before Tax -57034000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20240331 Income Tax Expense Benefit -1464000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20250331 Income Tax Expense Benefit -6223000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20240331 Increase Decrease In Deferred Policy Acquisition Costs 94737000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Increase Decrease In Prepaid Reinsurance Premiums 240695000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Interest Paid Net 17504000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Interest Receivable 108392000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Investments 15042062000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Liability For Claims And Claims Adjustment Expense 17218929000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Net Cash Provided By Used In Financing Activities -123499000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Net Income Loss 194071000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Net Income Loss Available To Common Stockholders Basic 186508000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Operating Lease Right Of Use Asset 92516000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent -37062000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20250331 Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent 115337000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Other Operating Income Expense Net 8340000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Other Operating Income Expense Net 3578000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Payments For Advance To Affiliate 101229000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Payments Related To Tax Withholding For Share Based Compensation 14121000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Payments To Acquire Available For Sale Securities Debt 2450714000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments To Acquire Equity Securities Fv Ni 73063000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Preferred Stock Value 550000000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Proceeds From Sale And Collection Of Mortgage Notes Receivable 211000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Proceeds From Sale Of Short Term Investments 228673000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Receivables From Brokers Dealers And Clearing Organizations 39498000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax -28087000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20250331 Reinsurance Recoverable For Unpaid Claims And Claims Adjustments 6944518000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Restricted Cash And Cash Equivalents 920150000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Retained Earnings Accumulated Deficit 7341569000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Selling General And Administrative Expense 10846000.0000 USD 1 us-gaap/2024 Business Segments= Reinsurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Selling General And Administrative Expense 130438000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001214816-25-000115 20231231 Stockholders Equity 6440528000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001214816-25-000115 20240331 Stockholders Equity 5505155000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Stockholders Equity -41940000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0001214816-25-000115 20241231 Stockholders Equity 2394063000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001214816-25-000115 20241231 Stockholders Equity 7341569000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001214816-25-000115 20250331 Stockholders Equity -152376000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001214816-25-000115 20240331 Stock Issued During Period Value Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations -26312000.0000 USD 1 0001214816-25-000115 Equity Components= Additional Paid In Capital;
0001214816-25-000115 20250331 Stock Issued During Period Value Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations 31089000.0000 USD 1 0001214816-25-000115 Equity Components= Treasury Stock Common;
0001214816-25-000115 20240331 Treasury Stock Value Acquired Cost Method 75728000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001214816-25-000115 20241231 Alternative Investment 92230000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20241231 Alternative Investment 24919000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20241231 Alternative Investment 3000000.0000 USD 0 us-gaap/2024 Investment Type= Direct Lending Funds; Redemption Frequency= Quarterly Redemption;
0001214816-25-000115 20241231 Alternative Investment 51000000.0000 USD 0 us-gaap/2024 Investment Type= Real Estate Funds; Redemption Frequency= Quarterly Redemption;
0001214816-25-000115 20250331 Alternative Investment 82000000.0000 USD 0 us-gaap/2024 Fair Value By Asset Class= Other Privately Held Investments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Valuation Technique= Market Approach Valuation Technique;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Real Estate Funds;
0001214816-25-000115 20250331 Alternative Investment 16625000.0000 USD 0 us-gaap/2024 Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20250331 Alternative Investment 329542000.0000 USD 0 us-gaap/2024 Investment Type= Private Equity Funds;
0001214816-25-000115 20250331 Amortization Of Intangible Assets 2729000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20250331 Benefits Losses And Expenses 1286004000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 269146000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Ceded Premiums Written 25000000.0000 USD 1 us-gaap/2024 Counterparty Name= Third Party Reinsurer; Related Party Transaction= Retrocession Agreement With Third Party Reinsurer; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20250331 Common Stock Value 2206000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 53000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 195000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 1245681000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 719115000.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 195220000.0000 USD 0 us-gaap/2024 Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 12152753000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2767315000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 4842190000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 35837000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 166885000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 33143000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 72227000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001214816-25-000115 20241231 Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss 443400000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss 389571000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Deferred Policy Acquisition Cost Amortization Expense 194021000.0000 USD 1 us-gaap/2024 Business Segments= Insurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Deferred Policy Acquisition Cost Amortization Expense 70560000.0000 USD 1 us-gaap/2024 Business Segments= Reinsurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20241231 Deferred Policy Acquisition Costs 524837000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Earnings Per Share Basic 4.5700 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Earnings Per Share Diluted 2.2600 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Equity Securities Fv Ni 579274000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Equity Securities Fv Ni 316683000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001214816-25-000115 20241231 Equity Securities Fv Ni 2638000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Common Stock;
0001214816-25-000115 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001214816-25-000115 20241231 Equity Securities Fv Ni 256727000.0000 USD 0 us-gaap/2024 Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20250331 Equity Securities Fv Ni 251367000.0000 USD 0 us-gaap/2024 Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20250331 Equity Securities Fv Ni Cost 3061000.0000 USD 0 us-gaap/2024 Financial Instrument= Common Stock;
0001214816-25-000115 20240331 Increase Decrease Due From Affiliates -48000000.0000 USD 1 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Loan Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20250331 Increase Decrease Due From Affiliates -71000000.0000 USD 1 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Loan Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20240331 Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve 209390000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Increase Decrease In Reinsurance Recoverable 186791000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Intangible Assets Net Excluding Goodwill 173238000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Mortgage Loans On Real Estate Commercial And Consumer Net 457907000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Net Income Loss 395459000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Net Investment Gain Loss -9207000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20241231 Operating Lease Liability 106614000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Operating Lease Liability 107289000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Other Assets 695794000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax -60059000.0000 USD 1 us-gaap/2024 Credit Loss Status= Aoci Gain Loss Debt Securities Available For Sale Without Allowance For Credit Loss Parent; Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20241231 Other Liabilities 7000000.0000 USD 0 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Loan Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20250331 Other Operating Income Expense Net 156000.0000 USD 1 us-gaap/2024 Business Segments= Insurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20241231 Payables To Broker Dealers And Clearing Organizations 269728000.0000 USD 0 srt/2024
0001214816-25-000115 20250331 Payments For Advance To Affiliate 96000000.0000 USD 1 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Loan Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20240331 Payments For Repurchase Of Common Stock 61607000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Payments Of Dividends Common Stock 40208000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20161231 Payments To Acquire Equity Method Investments 108000000.0000 USD 4 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Harrington Reinsurance Holdings Limited;
0001214816-25-000115 20240331 Premiums Earned Net 917946000.0000 USD 1 us-gaap/2024 Business Segments= Insurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Premiums Earned Net 1340820000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Premiums Receivable Allowance For Doubtful Accounts 17825000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Prepaid Reinsurance Premiums 1936979000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Proceeds From Interest Received 5000000.0000 USD 1 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Loan Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20240331 Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 435700000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 369666000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax -23415000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0001214816-25-000115 20250331 Retained Earnings Accumulated Deficit 7492484000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Selling General And Administrative Expense 119592000.0000 USD 1 us-gaap/2024 Business Segments= Insurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -267557000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Additional Paid In Capital Common Stock 2394063000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Private Equity Funds;
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Real Estate Funds;
0001214816-25-000115 20241231 Alternative Investment 171048000.0000 USD 0 us-gaap/2024 Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20241231 Alternative Investment 24919000.0000 USD 0 us-gaap/2024 Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Real Estate Funds;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20250331 Alternative Investment 16625000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20250331 Alternative Investment 329542000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Private Equity Funds;
0001214816-25-000115 20250331 Alternative Investment 291564000.0000 USD 0 us-gaap/2024 Financial Instrument= Real Estate Funds;
0001214816-25-000115 20240331 Amortization Of Intangible Assets 2729000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0001214816-25-000115 20241231 Assets 32520293000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Benefits Losses And Expenses 1154921000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3063621000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Common Stock Shares Outstanding 78651000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20240331 Comprehensive Income Net Of Tax 349446000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Advances From Federal Home Loan Banks 66380000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Accretion Amortization Of Discounts And Premiums Investments 8630000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Accretion Amortization Of Discounts And Premiums Investments 10621000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Advances From Federal Home Loan Banks 66000000.0000 USD 0 us-gaap/2024 Federal Home Loan Bank Advances Branch Of F H L B Bank= Federal Home Loan Bank Of Chicago;
0001214816-25-000115 20240331 Allowance For Credit Loss Period Increase Decrease 4664000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20241231 Alternative Investment 930278000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Hedge Funds Multistrategy;
0001214816-25-000115 20241231 Alternative Investment 171048000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20241231 Alternative Investment 291640000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Real Estate Funds;
0001214816-25-000115 20250331 Alternative Investment 15376000.0000 USD 0 us-gaap/2024 Fair Value By Asset Class= Other Privately Held Investments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Valuation Technique= Valuation Technique Discounted Cash Flow;
0001214816-25-000115 20250331 Alternative Investment 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Private Equity Funds;
0001214816-25-000115 20250331 Alternative Investment 97020000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Other Privately Held Investments;
0001214816-25-000115 20250331 Alternative Investment 167425000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Measured At Net Asset Value Per Share; Financial Instrument= Direct Lending Funds;
0001214816-25-000115 20250331 Alternative Investment 2000000.0000 USD 0 us-gaap/2024 Investment Type= Direct Lending Funds; Redemption Frequency= Quarterly Redemption;
0001214816-25-000115 20250331 Alternative Investment 291564000.0000 USD 0 us-gaap/2024 Investment Type= Real Estate Funds;
0001214816-25-000115 20250331 Alternative Investment 22000000.0000 USD 0 us-gaap/2024 Investment Type= Real Estate Funds; Redemption Frequency= Annual Redemption;
0001214816-25-000115 20250331 Amortization Of Intangible Assets 2729000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20231231 Common Stock Shares Issued 176580000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20241231 Common Stock Shares Issued 176580000.0000 shares 0 us-gaap/2024
0001214816-25-000115 20250331 Common Stock Shares Issued 176580000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20231231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 10759000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 2830111000.0000 USD 0 us-gaap/2024 Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Foreign Government Debt Securities;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S Treasury And Government;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 167000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Valuation Technique= Market Approach Valuation Technique;
0001214816-25-000115 20240331 Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff 8000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20250331 Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss 320694000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss 122706000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20240331 Deferred Policy Acquisition Cost Amortization Expense 254254000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Deferred Policy Acquisition Cost Amortization Expense 254254000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001214816-25-000115 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20241231 Equity Securities Fv Ni 3000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Preferred Stock;
0001214816-25-000115 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Preferred Stock;
0001214816-25-000115 20240331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 8113000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 23378000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 25862000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Goodwill 66498000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Held To Maturity Securities Fair Value 436751000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Held To Maturity Securities Fair Value 115617000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Held To Maturity Securities Fair Value 123093000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -34310000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20240331 Income Tax Expense Benefit -124654000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Income Tax Expense Benefit 44322000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Intangible Assets Net Excluding Goodwill 175967000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20231231 Liability For Claims And Claims Adjustment Expense 16434018000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Net Investment Gain Loss -30005000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20240331 Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent -37062000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent -156000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent -46013000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Other Liabilities 430588000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Other Operating Income Expense Net 3578000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Other Short Term Investments 91330000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Payments For Proceeds From Productive Assets 8208000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments To Acquire Held To Maturity Securities 9950000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Payments To Acquire Short Term Investments 82199000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Preferred Stock Dividends Income Statement Impact 7563000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Proceeds From Sale And Collection Of Mortgage Notes Receivable 35579000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Reinsurance Payable 1883746000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Selling General And Administrative Expense 122087000.0000 USD 1 us-gaap/2024 Business Segments= Insurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20231231 Stockholders Equity -365836000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001214816-25-000115 20240331 Stockholders Equity 6790558000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001214816-25-000115 20241231 Stockholders Equity 6089379000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Stockholders Equity -42096000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0001214816-25-000115 20241231 Treasury Stock Common Shares 93596000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20250331 Treasury Stock Common Shares 97929000.0000 shares 0 us-gaap/2024
0001214816-25-000115 20250331 Treasury Stock Value Acquired Cost Method 464506000.0000 USD 1 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 1519000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Asset Backed Securities Securitized Loans And Receivables;
0001214816-25-000115 20241231 Debt Securities Available For Sale Excluding Accrued Interest 126391000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Corporate Debt Securities;
0001214816-25-000115 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Commercial Mortgage Backed Securities;
0001214816-25-000115 20250331 Dividends Common Stock Cash 35593000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings; Refer to Note 9 'Shareholders' Equity' for details on dividends declared and paid related to the Company's common and preferred shares.
0001214816-25-000115 20250331 Earnings Per Share Basic 2.3000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Equity Method Investments 206994000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Equity Securities Fv Ni 314508000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20250331 Equity Securities Fv Ni 5885000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Preferred Stock;
0001214816-25-000115 20241231 Equity Securities Fv Ni Cost 3061000.0000 USD 0 us-gaap/2024 Financial Instrument= Common Stock;
0001214816-25-000115 20241231 Equity Securities Fv Ni Cost 323068000.0000 USD 0 us-gaap/2024 Financial Instrument= Non United States Bond Mutual Fund;
0001214816-25-000115 20250331 Equity Securities Fv Ni Cost 235124000.0000 USD 0 us-gaap/2024 Financial Instrument= Exchange Traded Funds;
0001214816-25-000115 20250331 Foreign Currency Transaction Gain Loss Before Tax -57034000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Held To Maturity Securities Fair Value 383827000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Income Taxes Paid Net 12770000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Increase Decrease In Accrued Investment Income Receivable -5503000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Increase Decrease In Deferred Policy Acquisition Costs 103121000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Increase Decrease In Premiums Receivable And Reinsurance Payable Net 267456000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20241231 Interest Receivable 114012000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Investment Income Net For Investments And Cash And Cash Equivalents 207713000.0000 USD 1 0001214816-25-000115
0001214816-25-000115 20240331 Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 728671000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Net Cash Provided By Used In Operating Activities 309079000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Net Income Loss -23415000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income;
0001214816-25-000115 20250331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent -156000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0001214816-25-000115 20250331 Other Depreciation And Amortization 13792000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Payments To Acquire Equity Method Investments 14000000.0000 USD 4 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Monarch Point Re;
0001214816-25-000115 20240331 Payments To Acquire Other Investments 18368000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments To Acquire Other Investments 20729000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Payments To Acquire Short Term Investments 196153000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20250331 Preferred Stock Value 550000000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Premiums Earned Net 1258041000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Premiums Earned Net 330734000.0000 USD 1 us-gaap/2024 Business Segments= Reinsurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Proceeds From Sale Of Available For Sale Securities Debt 2872156000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20241231 Receivables From Brokers Dealers And Clearing Organizations 3693000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Treasury Stock Value Acquired Cost Method 439992000.0000 USD 1 us-gaap/2024 Class Of Stock= Common Stock; Share Repurchase Type= Open Market;
0001214816-25-000115 20240331 Reinsurance Effect On Claims And Benefits Incurred Amount Ceded 4000000.0000 USD 1 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Retrocession Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20250331 Reinsurance Effect On Claims And Benefits Incurred Amount Ceded 14000000.0000 USD 1 us-gaap/2024 Counterparty Name= Monarch Point Re; Related Party Transaction= Retrocession Agreement With Monarch Point Re; Related Party Transactions By Related Party= Related Party;
0001214816-25-000115 20240331 Reinsurance Recoverable For Unpaid Claims And Claims Adjustments 6503188000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20241231 Reinsurance Recoverable For Unpaid Claims And Claims Adjustments 6840897000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Selling General And Administrative Expense 163373000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Selling General And Administrative Expense 15706000.0000 USD 1 us-gaap/2024 Business Segments= Reinsurance; Consolidation Items= Operating Segments;
0001214816-25-000115 20250331 Selling General And Administrative Expense 28725000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001214816-25-000115 20240331 Share Based Compensation 13670000.0000 USD 1 us-gaap/2024
0001214816-25-000115 20240331 Stockholders Equity -27128000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0001214816-25-000115 20240331 Stockholders Equity 2368144000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001214816-25-000115 20240331 Stockholders Equity -3793904000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001214816-25-000115 20250331 Stockholders Equity 5902799000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20250331 Stockholders Equity 2206000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001214816-25-000115 20231231 Treasury Stock Common Shares 91294000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20240331 Treasury Stock Common Shares 91893000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock;
0001214816-25-000115 20241231 Treasury Stock Common Value 3930902000.0000 USD 0 us-gaap/2024
0001214816-25-000115 20240331 Treasury Stock Value Acquired Cost Method 14121000.0000 USD 1 us-gaap/2024 Class Of Stock= Common Stock; Share Repurchase Type= Employees;
0001214816-25-000115 20240331 Treasury Stock Value Acquired Cost Method 61607000.0000 USD 1 us-gaap/2024 Class Of Stock= Common Stock; Share Repurchase Type= Open Market;
0001214816-25-000115 20250331 Treasury Stock Value Acquired Cost Method 464506000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001214816-25-000115 20250331 Weighted Average Number Of Diluted Shares Outstanding 82378000.0000 shares 1 us-gaap/2024
0001214816-25-000115 20240331 Weighted Average Number Of Shares Outstanding Basic 84879000.0000 shares 1 us-gaap/2024
0001214816-25-000115 20250331 Weighted Average Number Of Shares Outstanding Basic 81152000.0000 shares 1 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Payments For Proceeds From Productive Assets us-gaap/2024 0 0 monetary D C Payments for (Proceeds from) Productive Assets The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles.
Payments To Acquire Equity Method Investments us-gaap/2024 0 0 monetary D C Payments to Acquire Equity Method Investments The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Other Depreciation And Amortization us-gaap/2024 0 0 monetary D D Other Depreciation and Amortization Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.
Payments To Acquire Equity Securities Fv Ni us-gaap/2024 0 0 monetary D C Payments to Acquire Equity Securities, FV-NI Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.
Alternative Investment us-gaap/2024 0 0 monetary I D Alternative Investment Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Deferred Policy Acquisition Costs us-gaap/2024 0 0 monetary I D Deferred Policy Acquisition Cost Amount of deferred policy acquisition cost capitalized on contract remaining in force.
Equity Securities Fv Ni us-gaap/2024 0 0 monetary I D Equity Securities, FV-NI, Current Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.
Increase Decrease In Prepaid Reinsurance Premiums us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Reinsurance Premiums The change in prepaid reinsurance premiums recorded on the balance sheet, which is needed to adjust net income to arrive at net cash flows provided by or used in operations.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Payments To Acquire Mortgage Notes Receivable us-gaap/2024 0 0 monetary D C Payments to Acquire Mortgage Notes Receivable The cash outflow from the purchase of receivables arising from the mortgage note on real estate.
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities us-gaap/2024 0 0 monetary D D Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity.
Proceeds From Sale And Collection Of Mortgage Notes Receivable us-gaap/2024 0 0 monetary D D Proceeds from Sale and Collection of Mortgage Notes Receivable The cash inflow from proceeds from sale of receivables arising from the mortgage note on real estate; includes collections on mortgage notes receivable that are not classified as operating cash flows.
Reinsurance Recoverables Allowance us-gaap/2024 0 0 monetary I C Reinsurance Recoverable, Allowance for Credit Loss Amount of allowance for credit loss on reinsurance recoverable.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Issued During Period Value Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations 0001214816-25-000115 1 0 monetary D C Stock Issued During Period, Value, Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations Equity impact of the value of treasury stock (units) reissued during the period. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding.
Held To Maturity Securities Fair Value us-gaap/2024 0 0 monetary I D Debt Securities, Held-to-Maturity, Fair Value Fair value of investment in debt security measured at amortized cost (held-to-maturity).
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax us-gaap/2024 0 0 monetary D D Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Amount after tax of reclassification adjustments of other comprehensive income (loss).
Reinsurance Recoverables On Paid Losses us-gaap/2024 0 0 monetary I D Reinsurance Recoverable for Paid Claims and Claims Adjustments Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to and paid by the ceding insurer.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Advances From Federal Home Loan Banks us-gaap/2024 0 0 monetary I C Advance from Federal Home Loan Bank Amount of borrowings as of the balance sheet date from the Federal Home Loan Bank, which are primarily used to cover shortages in the required reserve balance and liquidity shortages.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 0 0 monetary I C Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest Amount, excluding accrued interest, of allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity).
Dividends Common Stock Cash us-gaap/2024 0 0 monetary D D Dividends, Common Stock, Cash Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Equity Securities Fv Ni Cost us-gaap/2024 0 0 monetary I D Equity Securities, FV-NI, Cost Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.
Increase Decrease In Accrued Investment Income Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accrued Investment Income Receivable The increase (decrease) during the reporting period in investment income that has been earned but not yet received in cash.
Interest Expense us-gaap/2024 0 0 monetary D D Interest Expense, Operating and Nonoperating Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.
Marketable Securities Gain Loss Excluding Other Than Temporary Impairments us-gaap/2024 0 0 monetary D C Marketable Security, Gain (Loss) Amount of realized and unrealized gain (loss) on investment in marketable security.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Premiums Receivable At Carrying Value us-gaap/2024 0 0 monetary I D Premiums Receivable, Net The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.
Unearned Premiums us-gaap/2024 0 0 monetary I C Unearned Premiums Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.
Increase Decrease In Reinsurance Recoverable On Paid Losses And Loss Expenses 0001214816-25-000115 1 0 monetary D C Increase (Decrease) In Reinsurance Recoverable On Paid Losses And Loss Expenses The increase (decrease) during the reporting period in the amount of reinsurance recoverable on paid losses and loss expenses.
Investment Income Net For Investments And Cash And Cash Equivalents 0001214816-25-000115 1 0 monetary D C Investment Income Net For Investments And Cash And Cash Equivalents The net gain or loss (both realized and unrealized) related to investments in certain entities that calculate net asset value per share and the amount after accretion (amortization) of discount (premium) of interest income and dividend income on nonoperating securities, net of investment expense.
Benefits Losses And Expenses us-gaap/2024 0 0 monetary D D Benefits, Losses and Expenses The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.
Ceded Premiums Written us-gaap/2024 0 0 monetary D D Ceded Premiums Written Amount of written premiums ceded to other entities.
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve us-gaap/2024 0 0 monetary D D Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.
Increase Decrease In Other Operating Capital Net us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Operating Assets and Liabilities, Net Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.
Operating Lease Liability us-gaap/2024 0 0 monetary I C Operating Lease, Liability Present value of lessee's discounted obligation for lease payments from operating lease.
Other Operating Income Expense Net us-gaap/2024 0 0 monetary D C Other Operating Income (Expense), Net The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.
Payments To Acquire Available For Sale Securities Debt us-gaap/2024 0 0 monetary D C Payments to Acquire Debt Securities, Available-for-Sale Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Payments To Acquire Other Investments us-gaap/2024 0 0 monetary D C Payments to Acquire Other Investments Amount of cash outflow to acquire investments classified as other.
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments us-gaap/2024 0 0 monetary D D Proceeds from Maturities, Prepayments and Calls of Short-Term Investments The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Selling General And Administrative Expense us-gaap/2024 0 0 monetary D D Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Equity Method Investments us-gaap/2024 0 0 monetary I D Equity Method Investments This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2024 0 0 monetary I D Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.
Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 0 0 monetary D C Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Proceeds From Sale Of Short Term Investments us-gaap/2024 0 0 monetary D D Proceeds from Sale of Short-Term Investments The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Reinsurance Effect On Claims And Benefits Incurred Amount Ceded us-gaap/2024 0 0 monetary D C Policyholder Benefits and Claims Incurred, Ceded Amount of reduction of provision for policy benefits and costs incurred for policies ceded.
Notes Payable us-gaap/2024 0 0 monetary I C Notes Payable Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Premiums Earned Net us-gaap/2024 0 0 monetary D C Premiums Earned, Net Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.
Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff us-gaap/2024 0 0 monetary D D Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Writeoff Amount, excluding accrued interest, of decrease in allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) from writeoff.
Deferred Policy Acquisition Cost Amortization Expense us-gaap/2024 0 0 monetary D D Deferred Policy Acquisition Costs, Amortization Expense Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.
Goodwill us-gaap/2024 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Intangible Assets Net Excluding Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Liability For Claims And Claims Adjustment Expense us-gaap/2024 0 0 monetary I C Liability for Claims and Claims Adjustment Expense The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.
Other Short Term Investments us-gaap/2024 0 0 monetary I D Other Short-Term Investments Amount of short-term investments classified as other.
Proceeds From Interest Received us-gaap/2024 0 0 monetary D D Proceeds from Interest Received Interest received on loans and other debt instruments during the current period.
Proceeds From Sale Of Equity Securities Fv Ni us-gaap/2024 0 0 monetary D D Proceeds from Sale of Equity Securities, FV-NI Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.
Payables To Broker Dealers And Clearing Organizations srt/2024 0 0 monetary I C Broker-Dealer, Payable to Other Broker-Dealer and Clearing Organization Amount payable to other broker-dealer and clearing organization, including, but not limited to, security failed-to-receive, deposit received for security loaned, open transaction, and floor-brokerage payable.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Increase Decrease In Premiums Receivable And Reinsurance Payable Net 0001214816-25-000115 1 0 monetary D C (Increase) Decrease In Premiums Receivable And Reinsurance Payable Net The net change in the premium receivable and the amount due to other insurance companies on the balance sheet.
Dividends Preferred Stock Cash us-gaap/2024 0 0 monetary D D Dividends, Preferred Stock, Cash Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.
Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss us-gaap/2024 0 0 monetary I D Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 us-gaap/2024 0 0 monetary D D Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Amount after tax of other comprehensive income (loss) attributable to parent entity.
Revenues us-gaap/2024 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Additional Paid In Capital Common Stock us-gaap/2024 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Amortization Of Intangible Assets us-gaap/2024 0 0 monetary D D Amortization of Intangible Assets The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.
Debt Securities Available For Sale Excluding Accrued Interest us-gaap/2024 0 0 monetary I D Debt Securities, Available-for-Sale, Excluding Accrued Interest Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Interest Receivable us-gaap/2024 0 0 monetary I D Interest Receivable Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Net Income Loss Available To Common Stockholders Basic us-gaap/2024 0 0 monetary D C Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
Payments For Advance To Affiliate us-gaap/2024 0 0 monetary D C Payments for Advance to Affiliate The cash outflow from advancing money to an affiliate (an entity that is related but not strictly controlled by the entity).
Other Liabilities us-gaap/2024 0 0 monetary I C Other Liabilities Amount of liabilities classified as other.
Payments For Repurchase Of Common Stock us-gaap/2024 0 0 monetary D C Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period.
Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 0 0 monetary D C Payment, Tax Withholding, Share-Based Payment Arrangement Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.
Payments To Acquire Held To Maturity Securities us-gaap/2024 0 0 monetary D C Payments to Acquire Held-to-Maturity Securities Amount of cash outflow through purchase of long-term held-to-maturity securities.
Premiums Receivable Allowance For Doubtful Accounts us-gaap/2024 0 0 monetary I C Premium Receivable, Allowance for Credit Loss The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.
Prepaid Reinsurance Premiums us-gaap/2024 0 0 monetary I D Prepaid Reinsurance Premiums The unexpired portion of premiums ceded on policies in force as of the balance sheet date.
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities us-gaap/2024 0 0 monetary D D Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Proceeds From Sale And Maturity Of Other Investments us-gaap/2024 0 0 monetary D D Proceeds from Sale and Maturity of Other Investments The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.
Reinsurance Recoverable For Unpaid Claims And Claims Adjustments us-gaap/2024 0 0 monetary I D Reinsurance Recoverable for Unpaid Claims and Claims Adjustments Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.
Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2024 0 0 monetary D D Proceeds from Sale of Debt Securities, Available-for-Sale Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Accretion Amortization Of Discounts And Premiums Investments us-gaap/2024 0 0 monetary D C Accretion (Amortization) of Discounts and Premiums, Investments The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.
Receivables From Brokers Dealers And Clearing Organizations us-gaap/2024 0 0 monetary I D Receivable from Broker-Dealer and Clearing Organization Amount receivable from broker-dealers and clearing organizations, including, but not limited to, securities failed-to-deliver, certain deposits for securities borrowed, open transactions, good faith and margin deposits, commissions and floor brokerage receivables.
Net Investment Gain Loss 0001214816-25-000115 1 0 monetary D C Net Investment Gain (Loss) This item represents the net realized gains and losses on available for sale debt securities, the net realized and unrealized gains and losses on equity securities with FV recorded in net income, together with the change in fair value of investment derivatives, and expected and realized credit losses.
Net Realized And Unrealized Gain Loss On Alternative Investments 0001214816-25-000115 1 0 monetary D C Net Realized And Unrealized Gain Loss On Alternative Investments Net realized and the change in net unrealized (gains) losses related to investments in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest . Investments include, but are not limited to, investments in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 0 0 monetary I C Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
Financing Receivable Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 0 0 monetary I C Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.
Increase Decrease In Reinsurance Recoverable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Reinsurance Recoverable The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types.
Increase Decrease In Unearned Premiums us-gaap/2024 0 0 monetary D D Increase (Decrease) in Unearned Premiums Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.
Increase Decrease Due From Affiliates us-gaap/2024 0 0 monetary D C Increase (Decrease) Due from Affiliates The increase (decrease) during the reporting period in receivables to be collected from an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Restructuring Settlement And Impairment Provisions us-gaap/2024 0 0 monetary D D Restructuring, Settlement and Impairment Provisions Amount of restructuring charges, remediation cost, and asset impairment loss.
Preferred Stock Dividends Income Statement Impact us-gaap/2024 0 0 monetary D D Preferred Stock Dividends, Income Statement Impact The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.
Reinsurance Payable us-gaap/2024 0 0 monetary I C Reinsurance Payable The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements.
Restricted Cash And Cash Equivalents us-gaap/2024 0 0 monetary I D Restricted Cash and Cash Equivalents Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2024 0 0 monetary I D Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss Amount excluding accrued interest, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).
Treasury Stock Common Value us-gaap/2024 0 0 monetary I D Treasury Stock, Common, Value Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.
Investments us-gaap/2024 0 0 monetary I D Investments Sum of the carrying amounts as of the balance sheet date of all investments.
Increase Decrease In Deferred Policy Acquisition Costs us-gaap/2024 0 0 monetary D C Increase (Decrease) in Deferred Policy Acquisition Costs The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Mortgage Loans On Real Estate Commercial And Consumer Net us-gaap/2024 0 0 monetary I D Mortgage Loans on Real Estate, Commercial and Consumer, Net The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.
Other Assets us-gaap/2024 0 0 monetary I D Other Assets Amount of assets classified as other.
Payments Of Dividends Common Stock us-gaap/2024 0 0 monetary D C Payments of Ordinary Dividends, Common Stock Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.
Payments Of Dividends Preferred Stock And Preference Stock us-gaap/2024 0 0 monetary D C Payments of Ordinary Dividends, Preferred Stock and Preference Stock Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.
Payments To Acquire Short Term Investments us-gaap/2024 0 0 monetary D C Payments to Acquire Short-Term Investments The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Treasury Stock Common Shares us-gaap/2024 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.
Treasury Stock Value Acquired Cost Method us-gaap/2024 0 0 monetary D D Treasury Stock, Value, Acquired, Cost Method Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
Allowance For Credit Loss Period Increase Decrease 0001214816-25-000115 1 0 monetary D C Allowance for Credit Loss, Period Increase (Decrease) Amount of increase (decrease) in the total allowance for credit loss of investments.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001214816-25-000115 2 3 BS 0 H Debt Securities Available For Sale Excluding Accrued Interest us-gaap/2024 Fixed maturities, available for sale, at fair value (Amortized cost 2025: $11,997,330; 2024: $12,419,905 Allowance for expected credit losses 2025: $4,183; 2024: $3,938) 0
0001214816-25-000115 2 4 BS 0 H Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2024 Fixed maturities, held to maturity, at amortized cost (Fair value 2025: $383,827; 2024: $436,751 Allowance for expected credit losses 2025: $nil; 2024: $nil) 0
0001214816-25-000115 2 5 BS 0 H Equity Securities Fv Ni us-gaap/2024 Equity securities, at fair value (Cost 2025: $538,378; 2024: $520,743) 0
0001214816-25-000115 2 6 BS 0 H Mortgage Loans On Real Estate Commercial And Consumer Net us-gaap/2024 Mortgage loans, held for investment, at fair value (Allowance for expected credit losses 2025: $25,862; 2024: $23,378) 0
0001214816-25-000115 2 7 BS 0 H Alternative Investment us-gaap/2024 Other investments, at fair value 0
0001214816-25-000115 2 8 BS 0 H Equity Method Investments us-gaap/2024 Equity method investments 0
0001214816-25-000115 2 9 BS 0 H Other Short Term Investments us-gaap/2024 Short-term investments, at fair value 0
0001214816-25-000115 2 10 BS 0 H Investments us-gaap/2024 Total investments 0
0001214816-25-000115 2 11 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001214816-25-000115 2 12 BS 0 H Restricted Cash And Cash Equivalents us-gaap/2024 Restricted cash and cash equivalents 0
0001214816-25-000115 2 13 BS 0 H Interest Receivable us-gaap/2024 Accrued interest receivable 0
0001214816-25-000115 2 14 BS 0 H Premiums Receivable At Carrying Value us-gaap/2024 Insurance and reinsurance premium balances receivable (Allowance for expected credit losses 2025: $17,825; 2024: $17,339) 0
0001214816-25-000115 2 15 BS 0 H Reinsurance Recoverable For Unpaid Claims And Claims Adjustments us-gaap/2024 Reinsurance recoverable on unpaid losses and loss expenses (Allowance for expected credit losses 2025: $43,267; 2024: $43,445) 0
0001214816-25-000115 2 16 BS 0 H Reinsurance Recoverables On Paid Losses us-gaap/2024 Reinsurance recoverable on paid losses and loss expenses 0
0001214816-25-000115 2 17 BS 0 H Deferred Policy Acquisition Costs us-gaap/2024 Deferred acquisition costs 0
0001214816-25-000115 2 18 BS 0 H Prepaid Reinsurance Premiums us-gaap/2024 Prepaid reinsurance premiums 0
0001214816-25-000115 2 19 BS 0 H Receivables From Brokers Dealers And Clearing Organizations us-gaap/2024 Receivable for investments sold 0
0001214816-25-000115 2 20 BS 0 H Goodwill us-gaap/2024 Goodwill 0
0001214816-25-000115 2 21 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2024 Intangible assets 0
0001214816-25-000115 2 22 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use assets 0
0001214816-25-000115 2 23 BS 0 H Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2024 Loan advances made 0
0001214816-25-000115 2 24 BS 0 H Other Assets us-gaap/2024 Other assets 0
0001214816-25-000115 2 25 BS 0 H Assets us-gaap/2024 Total assets 0
0001214816-25-000115 2 27 BS 0 H Liability For Claims And Claims Adjustment Expense us-gaap/2024 Reserve for losses and loss expenses 0
0001214816-25-000115 2 28 BS 0 H Unearned Premiums us-gaap/2024 Unearned premiums 0
0001214816-25-000115 2 29 BS 0 H Reinsurance Payable us-gaap/2024 Insurance and reinsurance balances payable 0
0001214816-25-000115 2 30 BS 0 H Notes Payable us-gaap/2024 Debt 0
0001214816-25-000115 2 31 BS 0 H Advances From Federal Home Loan Banks us-gaap/2024 Federal Home Loan Bank advances 0
0001214816-25-000115 2 32 BS 0 H Payables To Broker Dealers And Clearing Organizations srt/2024 Payable for investments purchased 0
0001214816-25-000115 2 33 BS 0 H Operating Lease Liability us-gaap/2024 Operating lease liabilities 0
0001214816-25-000115 2 34 BS 0 H Other Liabilities us-gaap/2024 Other liabilities 0
0001214816-25-000115 2 35 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001214816-25-000115 2 37 BS 0 H Preferred Stock Value us-gaap/2024 Preferred shares 0
0001214816-25-000115 2 38 BS 0 H Common Stock Value us-gaap/2024 Common shares (shares issued 2025: 176,580; 2024: 176,580 shares outstanding 2025: 78,651; 2024: 82,984) 0
0001214816-25-000115 2 39 BS 0 H Additional Paid In Capital Common Stock us-gaap/2024 Additional paid-in capital 0
0001214816-25-000115 2 40 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive income (loss) 0
0001214816-25-000115 2 41 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Retained earnings 0
0001214816-25-000115 2 42 BS 0 H Treasury Stock Common Value us-gaap/2024 Treasury shares, at cost (2025: 97,929; 2024: 93,596) 1
0001214816-25-000115 2 43 BS 0 H Stockholders Equity us-gaap/2024 Total shareholders equity 0
0001214816-25-000115 2 44 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and shareholders equity 0
0001214816-25-000115 3 1 BS 1 H Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss us-gaap/2024 Amortized cost 0
0001214816-25-000115 3 2 BS 1 H Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 Fixed maturities, available for sale, allowance for credit loss 0
0001214816-25-000115 3 3 BS 1 H Held To Maturity Securities Fair Value us-gaap/2024 Fixed maturities, held to maturity, fair value 0
0001214816-25-000115 3 4 BS 1 H Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 Fixed maturities, held to maturity, allowance for credit loss 0
0001214816-25-000115 3 5 BS 1 H Equity Securities Fv Ni Cost us-gaap/2024 Equity securities, cost 0
0001214816-25-000115 3 6 BS 1 H Financing Receivable Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 Mortgage loans, held for investment, allowance for credit loss 0
0001214816-25-000115 3 7 BS 1 H Premiums Receivable Allowance For Doubtful Accounts us-gaap/2024 Allowance for expected credit losses on insurance and reinsurance premium balances receivable 0
0001214816-25-000115 3 8 BS 1 H Reinsurance Recoverables Allowance us-gaap/2024 Allowance for expected credit losses on reinsurance recoverable for unpaid losses and loss expenses 0
0001214816-25-000115 3 9 BS 1 H Common Stock Shares Issued us-gaap/2024 Common shares, shares issued (in shares) 0
0001214816-25-000115 3 10 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common shares, shares outstanding (in shares) 0
0001214816-25-000115 3 11 BS 1 H Treasury Stock Common Shares us-gaap/2024 Treasury shares, shares (in shares) 0
0001214816-25-000115 4 2 IS 0 H Premiums Earned Net us-gaap/2024 Net premiums earned 0
0001214816-25-000115 4 3 IS 0 H Investment Income Net For Investments And Cash And Cash Equivalents 0001214816-25-000115 Net investment income 0
0001214816-25-000115 4 4 IS 0 H Other Operating Income Expense Net us-gaap/2024 Other insurance related income 0
0001214816-25-000115 4 6 IS 0 H Allowance For Credit Loss Period Increase Decrease 0001214816-25-000115 (Increase) decrease in allowance for expected credit losses 0
0001214816-25-000115 4 7 IS 0 H Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff us-gaap/2024 Impairment losses 1
0001214816-25-000115 4 8 IS 0 H Marketable Securities Gain Loss Excluding Other Than Temporary Impairments us-gaap/2024 Other realized and unrealized investment gains (losses) 0
0001214816-25-000115 4 9 IS 0 H Net Investment Gain Loss 0001214816-25-000115 Total net investment gains (losses) 0
0001214816-25-000115 4 10 IS 0 H Revenues us-gaap/2024 Total revenues 0
0001214816-25-000115 4 12 IS 0 H Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 us-gaap/2024 Net losses and loss expenses 0
0001214816-25-000115 4 13 IS 0 H Deferred Policy Acquisition Cost Amortization Expense us-gaap/2024 Acquisition costs 0
0001214816-25-000115 4 14 IS 0 H Selling General And Administrative Expense us-gaap/2024 General and administrative expenses 0
0001214816-25-000115 4 15 IS 0 H Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 Foreign exchange losses (gains) 1
0001214816-25-000115 4 16 IS 0 H Interest Expense us-gaap/2024 Interest expense and financing costs 0
0001214816-25-000115 4 17 IS 0 H Restructuring Settlement And Impairment Provisions us-gaap/2024 Reorganization expenses 0
0001214816-25-000115 4 18 IS 0 H Amortization Of Intangible Assets us-gaap/2024 Amortization of intangible assets 0
0001214816-25-000115 4 19 IS 0 H Benefits Losses And Expenses us-gaap/2024 Total expenses 0
0001214816-25-000115 4 20 IS 0 H Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments us-gaap/2024 Income before income taxes and interest in income of equity method investments 0
0001214816-25-000115 4 21 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax (expense) benefit 1
0001214816-25-000115 4 22 IS 0 H Income Loss From Equity Method Investments us-gaap/2024 Interest in income of equity method investments 0
0001214816-25-000115 4 23 IS 0 H Net Income Loss us-gaap/2024 Net income 0
0001214816-25-000115 4 24 IS 0 H Preferred Stock Dividends Income Statement Impact us-gaap/2024 Preferred share dividends 0
0001214816-25-000115 4 25 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2024 Net income available to common shareholders 0
0001214816-25-000115 4 28 IS 0 H Earnings Per Share Basic us-gaap/2024 Earnings per common share (in usd per share) 0
0001214816-25-000115 4 29 IS 0 H Earnings Per Share Diluted us-gaap/2024 Earnings per diluted common share (in usd per share) 0
0001214816-25-000115 4 30 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average common shares outstanding (in shares) 0
0001214816-25-000115 4 31 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average diluted common shares outstanding (in shares) 0
0001214816-25-000115 5 10 CI 0 H Net Income Loss us-gaap/2024 Net income 0
0001214816-25-000115 5 13 CI 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Unrealized gains (losses) arising during period 0
0001214816-25-000115 5 14 CI 0 H Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax us-gaap/2024 Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income 1
0001214816-25-000115 5 15 CI 0 H Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 Unrealized gains (losses) arising during the period, net of reclassification adjustment 0
0001214816-25-000115 5 16 CI 0 H Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 Foreign currency translation adjustment 0
0001214816-25-000115 5 17 CI 0 H Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent us-gaap/2024 Total other comprehensive income (loss), net of tax 0
0001214816-25-000115 5 18 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive income 0
0001214816-25-000115 6 14 EQ 0 H Stockholders Equity us-gaap/2024 Balance at beginning of period 0
0001214816-25-000115 6 15 EQ 0 H Stock Issued During Period Value Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations 0001214816-25-000115 Treasury shares reissued 0
0001214816-25-000115 6 16 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Share-based compensation expense 0
0001214816-25-000115 6 17 EQ 0 H Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 Unrealized gains (losses) arising during the period, net of reclassification adjustment 0
0001214816-25-000115 6 18 EQ 0 H Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 Foreign currency translation adjustment 0
0001214816-25-000115 6 19 EQ 0 H Net Income Loss us-gaap/2024 Net income 0
0001214816-25-000115 6 20 EQ 0 H Dividends Preferred Stock Cash us-gaap/2024 Preferred share dividends 1
0001214816-25-000115 6 21 EQ 0 H Dividends Common Stock Cash us-gaap/2024 Common share dividends 1
0001214816-25-000115 6 22 EQ 0 H Treasury Stock Value Acquired Cost Method us-gaap/2024 Shares repurchased 1
0001214816-25-000115 6 23 EQ 0 H Stockholders Equity us-gaap/2024 Balance at end of period 0
0001214816-25-000115 7 2 CF 0 H Net Income Loss us-gaap/2024 Net income 0
0001214816-25-000115 7 4 CF 0 H Net Investment Gain Loss 0001214816-25-000115 Net investment (gains) losses 1
0001214816-25-000115 7 5 CF 0 H Net Realized And Unrealized Gain Loss On Alternative Investments 0001214816-25-000115 Net realized and unrealized gains on other investments 1
0001214816-25-000115 7 6 CF 0 H Accretion Amortization Of Discounts And Premiums Investments us-gaap/2024 Amortization of fixed maturities 1
0001214816-25-000115 7 7 CF 0 H Income Loss From Equity Method Investments us-gaap/2024 Interest in income of equity method investments 1
0001214816-25-000115 7 8 CF 0 H Other Depreciation And Amortization us-gaap/2024 Other amortization and depreciation 0
0001214816-25-000115 7 9 CF 0 H Share Based Compensation us-gaap/2024 Share-based compensation expense 0
0001214816-25-000115 7 11 CF 0 H Increase Decrease In Accrued Investment Income Receivable us-gaap/2024 Accrued interest receivable 1
0001214816-25-000115 7 12 CF 0 H Increase Decrease In Reinsurance Recoverable us-gaap/2024 Reinsurance recoverable on unpaid losses and loss expenses 1
0001214816-25-000115 7 13 CF 0 H Increase Decrease In Reinsurance Recoverable On Paid Losses And Loss Expenses 0001214816-25-000115 Reinsurance recoverable on paid losses and loss expenses 1
0001214816-25-000115 7 14 CF 0 H Increase Decrease In Deferred Policy Acquisition Costs us-gaap/2024 Deferred acquisition costs 1
0001214816-25-000115 7 15 CF 0 H Increase Decrease In Prepaid Reinsurance Premiums us-gaap/2024 Prepaid reinsurance premiums 1
0001214816-25-000115 7 16 CF 0 H Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve us-gaap/2024 Reserve for losses and loss expenses 0
0001214816-25-000115 7 17 CF 0 H Increase Decrease In Unearned Premiums us-gaap/2024 Unearned premiums 0
0001214816-25-000115 7 18 CF 0 H Increase Decrease In Premiums Receivable And Reinsurance Payable Net 0001214816-25-000115 Insurance and reinsurance balances, net 1
0001214816-25-000115 7 19 CF 0 H Increase Decrease In Other Operating Capital Net us-gaap/2024 Other items 1
0001214816-25-000115 7 20 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash provided by operating activities 0
0001214816-25-000115 7 23 CF 0 H Payments To Acquire Available For Sale Securities Debt us-gaap/2024 Fixed maturities, available for sale 1
0001214816-25-000115 7 24 CF 0 H Payments To Acquire Held To Maturity Securities us-gaap/2024 Fixed maturities, held to maturity 1
0001214816-25-000115 7 25 CF 0 H Payments To Acquire Equity Securities Fv Ni us-gaap/2024 Equity securities 1
0001214816-25-000115 7 26 CF 0 H Payments To Acquire Mortgage Notes Receivable us-gaap/2024 Mortgage loans 1
0001214816-25-000115 7 27 CF 0 H Payments To Acquire Other Investments us-gaap/2024 Other investments 1
0001214816-25-000115 7 28 CF 0 H Payments To Acquire Equity Method Investments us-gaap/2024 Equity method investments 1
0001214816-25-000115 7 29 CF 0 H Payments To Acquire Short Term Investments us-gaap/2024 Short-term investments 1
0001214816-25-000115 7 31 CF 0 H Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2024 Fixed maturities, available for sale 0
0001214816-25-000115 7 32 CF 0 H Proceeds From Sale Of Equity Securities Fv Ni us-gaap/2024 Equity securities 0
0001214816-25-000115 7 33 CF 0 H Proceeds From Sale And Maturity Of Other Investments us-gaap/2024 Other investments 0
0001214816-25-000115 7 34 CF 0 H Proceeds From Sale Of Short Term Investments us-gaap/2024 Short-term investments 0
0001214816-25-000115 7 35 CF 0 H Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities us-gaap/2024 Proceeds from redemption of fixed maturities, available for sale 0
0001214816-25-000115 7 36 CF 0 H Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities us-gaap/2024 Proceeds from redemption of fixed maturities, held to maturity 0
0001214816-25-000115 7 37 CF 0 H Proceeds From Maturities Prepayments And Calls Of Shortterm Investments us-gaap/2024 Proceeds from redemption of short-term investments 0
0001214816-25-000115 7 38 CF 0 H Proceeds From Sale And Collection Of Mortgage Notes Receivable us-gaap/2024 Proceeds from the repayment of mortgage loans 0
0001214816-25-000115 7 39 CF 0 H Payments For Proceeds From Productive Assets us-gaap/2024 Proceeds from the purchase of other asset, net 1
0001214816-25-000115 7 40 CF 0 H Payments For Advance To Affiliate us-gaap/2024 Loan advances made 1
0001214816-25-000115 7 41 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash provided by investing activities 0
0001214816-25-000115 7 43 CF 0 H Payments For Repurchase Of Common Stock us-gaap/2024 Repurchase of common shares - open market 1
0001214816-25-000115 7 44 CF 0 H Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 Taxes paid on withholding shares 1
0001214816-25-000115 7 45 CF 0 H Payments Of Dividends Common Stock us-gaap/2024 Dividends paid - common shares 1
0001214816-25-000115 7 46 CF 0 H Payments Of Dividends Preferred Stock And Preference Stock us-gaap/2024 Dividends paid - preferred shares 1
0001214816-25-000115 7 47 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash used in financing activities 0
0001214816-25-000115 7 48 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of exchange rate changes on foreign currency cash, cash equivalents and restricted cash 0
0001214816-25-000115 7 49 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Increase in cash, cash equivalents and restricted cash 0
0001214816-25-000115 7 50 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash - beginning of period 0
0001214816-25-000115 7 51 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash - end of period 0
0001214816-25-000115 7 53 CF 0 H Income Taxes Paid Net us-gaap/2024 Income taxes paid 0
0001214816-25-000115 7 54 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001214816-25-000115 8 16 CF 1 H Increase Decrease Due From Affiliates us-gaap/2024 Non-cash repayment of advance 1
0001214816-25-000115 8 17 CF 1 H Ceded Premiums Written us-gaap/2024 Reinsurance premiums 0
0001214816-25-000115 8 18 CF 1 H Reinsurance Effect On Claims And Benefits Incurred Amount Ceded us-gaap/2024 Ceded losses and loss expenses 0
0001214816-25-000115 8 19 CF 1 H Proceeds From Interest Received us-gaap/2024 Interest received on advance 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.